Brain Cancer Research Today is a free monthly online journal that collates and summarizes the latest research about Brain Cancer, including details on symptoms, benign and malignant tumors, gliomas, treatment.

Volume 7 (2010), Issue 11 (November)

1. Common pathogenic pathways in melanoma and Parkinson disease.
   Neurology, 75(18): 1653-5. [Abstract] [Full-text]
2. Suprasellar arachnoid cyst resulting in the syndrome of inappropriate antidiuretic hormone secretion.
   J Neurosurg Pediatr, 6(5): 486-8. [Abstract] [Full-text]
3. Stereotactic radiosurgery for pediatric recurrent intracranial ependymomas.
   J Neurosurg Pediatr, 6(5): 417-23. [Abstract] [Full-text]
4. Surgical management of giant pediatric craniopharyngiomas.
   J Neurosurg Pediatr, 6(5): 403-16. [Abstract] [Full-text]
5. Factors affecting outcome following treatment of patients with cavernous sinus meningiomas.
   J Neurosurg, 113(5): 1087-92. [Abstract] [Full-text]
6. Lateral sellar angiolipoma: a tumor illustrative of the extradural compartment of the neural axis.
   J Neurosurg, 113(5): 1053-8. [Abstract] [Full-text]
7. High-definition fiber tracking guidance for intraparenchymal endoscopic port surgery.
   J Neurosurg, 113(5): 990-9. [Abstract] [Full-text]
8. Everolimus for subependymal giant-cell astrocytomas in tuberous sclerosis.
   N Engl J Med, 363(19): 1801-11. [Abstract] [Full-text]
9. Everolimus for subependymal giant-cell astrocytomas in tuberous sclerosis.
   N Engl J Med, 363(19): 1801-11. [Abstract] [Full-text]
10. In vivo assay of folate receptors in nonfunctional pituitary adenomas with 99mTc-folate SPECT/CT.
    J Nucl Med, 51(11): 1716-23. [Abstract] [Full-text]
11. Magnetic resonance imaging as a predictor of response to somatostatin analogs in acromegaly after surgical failure.
    J Clin Endocrinol Metab, 95(11): 4973-8. [Abstract] [Full-text]
12. Cushing's disease and idiopathic intracranial hypertension: case report and review of underlying pathophysiological mechanisms.
    J Clin Endocrinol Metab, 95(11): 4850-4. [Abstract] [Full-text]
13. Clinical characteristics and therapeutic responses in patients with germ-line AIP mutations and pituitary adenomas: an international collaborative study.
    J Clin Endocrinol Metab, 95(11): E373-83. [Abstract] [Full-text]
14. Temozolomide treatment for aggressive pituitary tumors: correlation of clinical outcome with O(6)-methylguanine methyltransferase (MGMT) promoter methylation and expression.
    J Clin Endocrinol Metab, 95(11): E280-90. [Abstract] [Full-text]
15. Gadolinium released from MR contrast agents is deposited in brain tumors: in situ demonstration using scanning electron microscopy with energy dispersive X-ray spectroscopy.
    Acta Radiol, 51(10): 1126-36. [Abstract] [Full-text]
16. Gadolinium released from MR contrast agents is deposited in brain tumors: in situ demonstration using scanning electron microscopy with energy dispersive X-ray spectroscopy.
    Acta Radiol, 51(10): 1126-36. [Abstract] [Full-text]
17. Salvage therapy with temozolomide in patients with aggressive or metastatic pituitary adenomas: experience in six cases.
    Eur J Endocrinol, 163(6): 843-51. [Abstract] [Full-text]
18. Salvage therapy with temozolomide in patients with aggressive or metastatic pituitary adenomas: experience in six cases.
    Eur J Endocrinol, 163(6): 843-51. [Abstract] [Full-text]
19. Retrovirally engineered T-cell-based immunotherapy targeting type III variant epidermal growth factor receptor, a glioma-associated antigen.
    Cancer Sci, 101(12): 2518-24. [Abstract] [Full-text]
20. Cerebrospinal fluid leak during treatment with bevacizumab and irinotecan after carmustine-impregnated wafers placement in patients with grade 2 oligodendroglioma and glioblastoma multiforme: report of two cases and review of literature.
    Cancer Invest, 28(10): 1048-53. [Abstract] [Full-text]
21. Retrovirally engineered T-cell-based immunotherapy targeting type III variant epidermal growth factor receptor, a glioma-associated antigen.
    Cancer Sci, 101(12): 2518-24. [Abstract] [Full-text]
22. Cerebrospinal fluid leak during treatment with bevacizumab and irinotecan after carmustine-impregnated wafers placement in patients with grade 2 oligodendroglioma and glioblastoma multiforme: report of two cases and review of literature.
    Cancer Invest, 28(10): 1048-53. [Abstract] [Full-text]
23. Survival and prognostic factors of early childhood medulloblastoma: an international meta-analysis.
    J Clin Oncol, 28(33): 4961-8. [Abstract] [Full-text]
24. Survival and prognostic factors of early childhood medulloblastoma: an international meta-analysis.
    J Clin Oncol, 28(33): 4961-8. [Abstract] [Full-text]
25. Preferential effect of synchrotron microbeam radiation therapy on intracerebral 9L gliosarcoma vascular networks.
    Int J Radiat Oncol Biol Phys, 78(5): 1503-12. [Abstract] [Full-text]
26. Ototoxicity after intensity-modulated radiation therapy and cisplatin-based chemotherapy in children with medulloblastoma.
    Int J Radiat Oncol Biol Phys, 78(5): 1445-50. [Abstract] [Full-text]
27. Initial experience with volumetric IMRT (RapidArc) for intracranial stereotactic radiosurgery.
    Int J Radiat Oncol Biol Phys, 78(5): 1457-66. [Abstract] [Full-text]
28. The value of 99mTc-tetrofosmin brain SPECT in predicting survival in patients with glioblastoma multiforme.
    J Nucl Med, 51(12): 1923-6. [Abstract] [Full-text]
29. Preferential effect of synchrotron microbeam radiation therapy on intracerebral 9L gliosarcoma vascular networks.
    Int J Radiat Oncol Biol Phys, 78(5): 1503-12. [Abstract] [Full-text]
30. High spatial resolution and high contrast visualization of brain arteries and veins: impact of blood pool contrast agent and water-selective excitation imaging at 3T.
    Rofo, 182(12): 1097-104. [Abstract] [Full-text]
31. Ototoxicity after intensity-modulated radiation therapy and cisplatin-based chemotherapy in children with medulloblastoma.
    Int J Radiat Oncol Biol Phys, 78(5): 1445-50. [Abstract] [Full-text]
32. Initial experience with volumetric IMRT (RapidArc) for intracranial stereotactic radiosurgery.
    Int J Radiat Oncol Biol Phys, 78(5): 1457-66. [Abstract] [Full-text]
33. Inducible expression of stem cell associated intermediate filament nestin reveals an important role in glioblastoma carcinogenesis.
    Int J Cancer, 128(2): 343-51. [Abstract] [Full-text]
34. Methylation patterns in cell-free plasma DNA reflect removal of the primary tumor and drug treatment of breast cancer patients.
    Int J Cancer, 128(2): 492-9. [Abstract] [Full-text]
35. Inducible expression of stem cell associated intermediate filament nestin reveals an important role in glioblastoma carcinogenesis.
    Int J Cancer, 128(2): 343-51. [Abstract] [Full-text]
36. Methylation patterns in cell-free plasma DNA reflect removal of the primary tumor and drug treatment of breast cancer patients.
    Int J Cancer, 128(2): 492-9. [Abstract] [Full-text]
37. Inducible expression of stem cell associated intermediate filament nestin reveals an important role in glioblastoma carcinogenesis.
    Int J Cancer, 128(2): 343-51. [Abstract] [Full-text]
38. Methylation patterns in cell-free plasma DNA reflect removal of the primary tumor and drug treatment of breast cancer patients.
    Int J Cancer, 128(2): 492-9. [Abstract] [Full-text]
39. A phase II study of metronomic oral topotecan for recurrent childhood brain tumors.
    Pediatr Blood Cancer, 56(1): 39-44. [Abstract] [Full-text]
40. Spectrum of pilomyxoid astrocytomas: intermediate pilomyxoid tumors.
    Am J Surg Pathol, 34(12): 1783-91. [Abstract] [Full-text]
41. Role of neoadjuvant chemotherapy in congenital intracranial haemangiopericytoma.
    Pediatr Blood Cancer, 56(1): 161-3. [Abstract] [Full-text]
42. A phase II study of metronomic oral topotecan for recurrent childhood brain tumors.
    Pediatr Blood Cancer, 56(1): 39-44. [Abstract] [Full-text]
43. Role of neoadjuvant chemotherapy in congenital intracranial haemangiopericytoma.
    Pediatr Blood Cancer, 56(1): 161-3. [Abstract] [Full-text]
44. A phase II study of metronomic oral topotecan for recurrent childhood brain tumors.
    Pediatr Blood Cancer, 56(1): 39-44. [Abstract] [Full-text]
45. Role of neoadjuvant chemotherapy in congenital intracranial haemangiopericytoma.
    Pediatr Blood Cancer, 56(1): 161-3. [Abstract] [Full-text]

© 2004-2012 Brain Cancer Research Today. All Rights Reserved.